As per Market Research Future (MRFR) analysis, the global platelet aggregation devices market share held a market value of USD 215.2 million in 2017 and is expected to grow at a CAGR of 21.50% from 2020 to 2030 (forecast period).
Platelet aggregation is a procedure in which human platelet cells are engaged in hemostasis, restore bleeding, and closure of vessels. Platelet aggregation plays a crucial function in inflammation and other pathological conditions. The platelet aggregation test in the anti-coagulant medium requires venipuncture. This is accompanied by centrifugation for platelet-rich plasma production, which uses an aggregometer to analyze the aggregation of platelets.
Factors that promote the growth of the demand for platelet aggregation devices are rising older populations worldwide, combined with an increasing prevalence of target diseases, a growing amount for industry-academia partnerships and clinical studies, and a rise in platelet aggregometer technology.
Nonetheless, the existence of unfavorable health reforms in the US and operational constraints are projected to curb demand growth over the forecast period. The World Health Organization (WHO) reported that the global population aged 60 years and over was 962.0 million in 2017, which is expected to increase to more than 2.0 billion by 2050 and to reach 3.1 billion by 2100.
Request Free Sample Copy at:
The global market for platelet aggregation devices has been segmented into product, application, and end-user.
By product, the global market for platelet aggregation devices has been segmented into systems, reagents, and consumables and accessories. In 2017, the systems segment dominated the market due to continuous technological advancements in sensors and detectors, increasing automation of platelet aggregation testing procedures, and growing adoption and market preference for automated instruments among diagnostic laboratories
Based on the application, the market has been divided into clinical applications and research applications. The clinical applications segment is further divided into cardiovascular applications, orthopedic applications, and others.
Based on end-user, the global market for platelet aggregation devices has been categorized into hospitals and clinics, diagnostic laboratories, research and academic institutes, and others.
Regionally, the global platelet aggregation devices market share has been segmented into the Americas, Europe, Asia Pacific, and the Middle East & Africa.
The Americas dominated the global market for platelet aggregation devices due to the presence of device manufacturers, a growing number of surgical procedures, increasing awareness among healthcare professionals (HCPs) about the benefits of platelet aggregation testing in the diagnosis of disease, and substantial investments in R&D activities using platelets. For example, as per the National Center for Health Statistics, around 48.0 million surgical inpatient procedures were conducted in the United States in 2009, which rose to 1.54 million by the end of 2017.
The availability of inexpensive platelet function tests and expanding distribution networks, a growing number of cardiovascular surgeries, new technical advances in platelet aggregators, and an increase in the number of clinical trials in the United Kingdom, Germany, and France are expected to sustain Europe's second-largest position on the global market. For example, according to data published by the European Medicines Agency (EMA) and the British Medical Journal, nearly 4,000 clinical trials of medicinal products are approved annually in the European Union (EU).
The Asia Pacific market would see the fastest growth during the forecast period ascribed to an increasing geriatric population coupled with a rising prevalence of chronic diseases, an increase in the adoption of new technological devices, and an increase in the incidence of mosquito-borne diseases, namely malaria, and dengue. Severe dengue is the leading cause of severe illness and death among children in some Asian and Latin American countries as per the World Health Organization. More than 40.0% of the world's population is at risk of dengue infection in more than 100 countries. The most serious dengue epidemics in recent years have reported in South East Asia, the Americas, and the Western Pacific. An approximate 390.0 million dengue infections occur worldwide every year.
The market for platelet aggregation devices in the Middle East and Africa are expected to have a modest market growth rate from 2018 and 2023 due to the adoption of new technologies, increasing prevalence of hemophilia disease, improving healthcare infrastructure and expanding market by various market players in the Gulf Cooperation Council ( GCC) countries, Israel and South Africa.
Some of the major participants in the global platelet aggregation devices market share are Siemens Healthineers, Hoffmann-La Roche Ltd, Haemonetics Corporation, Sysmex Corporation, Werfen, Helena Laboratories, Bio/Data Corporation, AggreDyne, Inc., Sentinel CH. SpA, Haemochrom Diagnostica GmbH, Pathway Diagnostics Limited.
Browse Detailed TOC with COVID-19 Impact Analysis at:
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071